CytomX Therapeutics Share Holder Equity 2014-2022 | CTMX
CytomX Therapeutics share holder equity from 2014 to 2022. Share holder equity can be defined as the sum of preferred and common equity items
CytomX Therapeutics Annual Share Holder Equity
(Millions of US $) |
| 2021 |
$89 |
| 2020 |
$50 |
| 2019 |
$51 |
| 2018 |
$131 |
| 2017 |
$70 |
| 2016 |
$78 |
| 2015 |
$126 |
| 2014 |
$-2 |
| 2013 |
$0 |
CytomX Therapeutics Quarterly Share Holder Equity
(Millions of US $) |
| 2022-09-30 |
$28 |
| 2022-06-30 |
$49 |
| 2022-03-31 |
$68 |
| 2021-12-31 |
$89 |
| 2021-09-30 |
$112 |
| 2021-06-30 |
$131 |
| 2021-03-31 |
$146 |
| 2020-12-31 |
$50 |
| 2020-09-30 |
$48 |
| 2020-06-30 |
$59 |
| 2020-03-31 |
$70 |
| 2019-12-31 |
$51 |
| 2019-09-30 |
$82 |
| 2019-06-30 |
$102 |
| 2019-03-31 |
$123 |
| 2018-12-31 |
$131 |
| 2018-09-30 |
$158 |
| 2018-06-30 |
$41 |
| 2018-03-31 |
$50 |
| 2017-12-31 |
$70 |
| 2017-09-30 |
$45 |
| 2017-06-30 |
$52 |
| 2017-03-31 |
$74 |
| 2016-12-31 |
$78 |
| 2016-09-30 |
$89 |
| 2016-06-30 |
$101 |
| 2016-03-31 |
$113 |
| 2015-12-31 |
$126 |
| 2015-09-30 |
$53 |
| 2015-06-30 |
$0 |
| 2015-03-31 |
$0 |
| 2014-12-31 |
|
| 2014-09-30 |
$0 |
| 2013-12-31 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.115B |
$0.070B |
|
CytomX Therapeutics, Inc. is an oncology focused biopharmaceutical company. The Company is engaged in developing Probody(TM) therapeutics for the treatment of cancer. Its pipeline focuses areas consist of Precision cancer immunotherapy and Probody drug conjugates. CytomX Therapeutics, Inc. is headquartered in South San Francisco, California.
|
